Transcriptomics

Dataset Information

0

Tumor-targeted IL-10 combined with IL-2 amplifies anti-tumor immunity


ABSTRACT: Tumor-targeting cytokines have emerged as a promising strategy for cancer immunotherapy, although their mechanisms of action often remain complex. In this study, we developed a novel approach by combining tumor-targeted IL-10 (CmAb-(IL10)2) with IL-2 (CmAb-IL2) to enhance antitumor immunity while minimizing Immune-Related Adverse Events (irAEs). We demonstrated that endogenous IL-10 plays a critical role in IL-2-mediated antitumor effects, and importantly, the combination of CmAb-(IL10)2 and CmAb-IL2 preferentially expands less-exhausted CD8+ T cells within tumors. Mechanistically, we identified that the IL-10/IL-10 receptor (IL-10R) axis in dendritic cells (DCs) is critical for mediating the efficacy of this combination therapy by promoting intratumoral DC function. Our findings reveal that tumor-targeted IL-10 synergizes with IL-2 to enhance antitumor immunity through the IL-10/IL-10R/DC axis within tumors, while mitigating IL-2-associated irAEs through the IL-10/IL-10R/macrophage axis. This approach offers a promising IL-10 based strategy to improve the efficacy of immunotherapy while reducing irAEs.

ORGANISM(S): Mus musculus

PROVIDER: GSE342584 | GEO | 2026/08/06

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2017-06-10 | GSE84980 | GEO
2014-05-09 | E-GEOD-56444 | biostudies-arrayexpress
2025-09-30 | GSE308698 | GEO
2015-12-21 | E-GEOD-58590 | biostudies-arrayexpress
2024-04-10 | GSE263108 | GEO
2011-10-19 | GSE25095 | GEO
2011-10-18 | E-GEOD-25095 | biostudies-arrayexpress
2024-02-09 | GSE247304 | GEO
2011-01-10 | GSE19941 | GEO
2015-12-21 | GSE58590 | GEO